Developer of a disruptive detection platform based on terawaves technology. The company provides a platform that specializes in disease detection, disease diagnosis, breath analysis, exhaled breath biomolecule identification and patient care.
Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
---|
This information is available in the PitchBook Platform. To explore TeraBAT‘s full profile, request access.
Request a free trialName | Title | Board Seat | Contact Info |
---|---|---|---|
Eyal Gerecht Ph.D | Co-Founder, President, Chief Technology Officer and Chief Executive Officer |
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|
This information is available in the PitchBook Platform. To explore TeraBAT‘s full profile, request access.
Request a free trial